Targeting of AID-Mediated Sequence Diversification by cis-Acting Determinants

Advances in Immunology

Volumn 94, Issue , 2007, Pages 109-125

  Yang, Shu Yuan ^a   Schatz, David G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; BETA ACTIN; CIS ACTING ELEMENT; CYTIDINE DERIVATIVE; DACTINOMYCIN; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; HISTONE; IMMUNOGLOBULIN; RNA; RNA POLYMERASE II; UNCLASSIFIED DRUG;

B LYMPHOCYTE; BURKITT LYMPHOMA; CLASS SWITCH RECOMBINATION; DEAMINATION; DNA STRUCTURE; ESCHERICHIA COLI; GENE LOCUS; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME; HUMAN; IMMUNOGLOBULIN GENE; MAMMAL CELL; METHYLATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REVIEW; RNA SYNTHESIS; SOMATIC MUTATION; TRANSGENE; VDJ EXON;

ANIMALS; ANTIBODY DIVERSITY; CYTIDINE DEAMINASE; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 34249810672     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(06)94004-8     Document Type: Review

References (84)

1. Arakawa H., Hauschild J., and Buerstedde J.M. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295 (2002) 1301-1306
2. Bachl J., Carlson C., Gray-Schopfer V., Dessing M., and Olsson C. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166 (2001) 5051-5057
3. Baumal R., Birshtein B.K., Coffino P., and Scharff M.D. Mutations in immunoglobulin-producing mouse myeloma cells. Science 182 (1973) 164-166
4. Bentley D.L. Rules of engagement: Co-transcriptional recruitment of pre-mRNA processing factors. Curr. Opin. Cell Biol. 17 (2005) 251-256
5. Besmer E., Market E., and Papavasiliou F.N. The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination. Mol. Cell. Biol. 26 (2006) 4378-4385
6. Betz A.G., Milstein C., Gonzalez-Fernandez A., Pannell R., Larson T., and Neuberger M.S. Elements regulating somatic hypermutation of an immunoglobulin kappa gene: Critical role for the intron enhancer/matrix attachment region. Cell 77 (1994) 239-248
7. Bottaro A., Lansford R., Xu L., Zhang J., Rothman P., and Alt F.W. S region transcription per se promotes basal IgE class switch recombination but additional factors regulate the efficiency of the process. EMBO J. 13 (1994) 665-674
8. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E., and Alt F.W. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422 (2003) 726-730
9. Conlon T.M., and Meyer K.B. The chicken Ig light chain 3′-enhancer is essential for gene expression and regulates gene conversion via the transcription factor E2A. Eur. J. Immunol. 36 (2006) 139-148
10. Di Noia J., and Neuberger M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419 (2002) 43-48
11. Di Noia J.M., and Neuberger M.S. Immunoglobulin gene conversion in chicken DT40 cells largely proceeds through an abasic site intermediate generated by excision of the uracil produced by AID-mediated deoxycytidine deamination. Eur. J. Immunol. 34 (2004) 504-508
12. Di Noia J.M., Rada C., and Neuberger M.S. SMUG1 is able to excise uracil from immunoglobulin genes: Insight into mutation versus repair. EMBO J. 25 (2006) 585-595
13. Dickerson S.K., Market E., Besmer E., and Papavasiliou F.N. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197 (2003) 1291-1296
14. Faili A., Aoufouchi S., Gueranger Q., Zober C., Leon A., Bertocci B., Weill J.C., and Reynaud C.A. AID-dependent somatic hypermutation occurs as a DNA single-strand event in the BL2 cell line. Nat. Immunol. 3 (2002) 815-821
15. Franco S., Gostissa M., Zha S., Lombard D.B., Murphy M.M., Zarrin A.A., Yan C., Tepsuporn S., Morales J.C., Adams M.M., Lou Z., Bassing C.H., et al. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol. Cell 21 (2006) 201-214
16. Fukita Y., Jacobs H., and Rajewsky K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity 9 (1998) 105-114
17. Goldfarb A.N., Flores J.P., and Lewandowska K. Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching. Mol. Immunol. 33 (1996) 947-956
18. Gordon M.S., Kanegai C.M., Doerr J.R., and Wall R. Somatic hypermutation of the B cell receptor genes B29 (Igbeta, CD79b) and mb1 (Igalpha, CD79a). Proc. Natl. Acad. Sci. USA 100 (2003) 4126-4131
19. Gourzi P., Leonova T., and Papavasiliou F.N. A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity 24 (2006) 779-786
20. Harris R.S., and Liddament M.T. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4 (2004) 868-877
21. Harris R.S., Sale J.E., Petersen-Mahrt S.K., and Neuberger M.S. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12 (2002) 435-438
22. Harvey C.A., and Downs J.A. What functions do linker histones provide?. Mol. Microbiol. 53 (2004) 771-775
23. Kee B.L., Quong M.W., and Murre C. E2A proteins: Essential regulators at multiple stages of B-cell development. Immunol. Rev. 175 (2000) 138-149
24. Kleinstein S.H., Louzoun Y., and Shlomchik M.J. Estimating hypermutation rates from clonal tree data. J. Immunol. 171 (2003) 4639-4649
25. Kuppers R., and Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20 (2001) 5580-5594
26. Landowski T.H., Qu N., Buyuksal I., Painter J.S., and Dalton W.S. Mutations in the Fas antigen in patients with multiple myeloma. Blood 90 (1997) 4266-4270
27. Larijani M., Frieder D., Sonbuchner T.M., Bransteitter R., Goodman M.F., Bouhassira E.E., Scharff M.D., and Martin A. Methylation protects cytidines from AID-mediated deamination. Mol. Immunol. 42 (2005) 599-604
28. Lebecque S.G., and Gearhart P.J. Boundaries of somatic mutation in rearranged immunoglobulin genes: 5′ boundary is near the promoter, and 3′ boundary is approximately 1 kb from V(D)J gene. J. Exp. Med. 172 (1990) 1717-1727
29. Li Z., Luo Z., and Scharff M.D. Differential regulation of histone acetylation and generation of mutations in switch regions is associated with Ig class switching. Proc. Natl. Acad. Sci. USA 101 (2004) 15428-15433
30. Lomvardas S., Barnea G., Pisapia D.J., Mendelsohn M., Kirkland J., and Axel R. Interchromosomal interactions and olfactory receptor choice. Cell 126 (2006) 403-413
31. Longerich S., Basu U., Alt F., and Storb U. AID in somatic hypermutation and class switch recombination. Curr. Opin. Immunol. 18 (2006) 164-174
32. Martin A., and Scharff M.D. Somatic hypermutation of the AID transgene in B and non-B cells. Proc. Natl. Acad. Sci. USA 99 (2002) 12304-12308
33. McBride K.M., Gazumyan A., Woo E.M., Barreto V.M., Robbiani D.F., Chait B.T., and Nussenzweig M.C. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 103 (2006) 8798-8803
34. McKean D., Huppi K., Bell M., Staudt L., Gerhard W., and Weigert M. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 81 (1984) 3180-3184
35. Michael N., Shen H.M., Longerich S., Kim N., Longacre A., and Storb U. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19 (2003) 235-242
36. Morgan H.D., Dean W., Coker H.A., Reik W., and Petersen-Mahrt S.K. Activation-induced cytidine deaminase deaminates 5-methylcytosine in DNA and is expressed in pluripotent tissues: Implications for epigenetic reprogramming. J. Biol. Chem. 279 (2004) 52353-52360
37. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
38. Muschen M., Re D., Jungnickel B., Diehl V., Rajewsky K., and Kuppers R. Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J. Exp. Med. 192 (2000) 1833-1840
39. Nambu Y., Sugai M., Gonda H., Lee C.G., Katakai T., Agata Y., Yokota Y., and Shimizu A. Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302 (2003) 2137-2140
40. Odegard V.H., and Schatz D.G. Targeting of somatic hypermutation. Nat. Rev. Immunol. 6 (2006) 573-583
41. Odegard V.H., Kim S.T., Anderson S.M., Shlomchik M.J., and Schatz D.G. Histone modifications associated with somatic hypermutation. Immunity 23 (2005) 101-110
42. Okazaki I.M., Kinoshita K., Muramatsu M., Yoshikawa K., and Honjo T. The AID enzyme induces class switch recombination in fibroblasts. Nature 416 (2002) 340-345
43. Papavasiliou F.N., and Schatz D.G. Cell-cycle-regulated DNA double-stranded breaks in somatic hypermutation of immunoglobulin genes. Nature 408 (2000) 216-221
44. Parsa J.Y., Basit W., Wang C.L., Gommerman J.L., Carlyle J.R., and Martin A. AID mutates a non-immunoglobulin transgene independent of chromosomal position. Mol. Immunol. 44 4 (2007) 567-575
45. Pasqualucci L., Migliazza A., Fracchiolla N., William C., Neri A., Baldini L., Chaganti R.S., Klein U., Kuppers R., Rajewsky K., and Dalla-Favera R. BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA 95 (1998) 11816-11821
46. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R., and Dalla-Favera R. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412 (2001) 341-346
47. Peters A., and Storb U. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4 (1996) 57-65
48. Petersen-Mahrt S.K., Harris R.S., and Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418 (2002) 99-103
49. Pham P., Bransteitter R., Petruska J., and Goodman M.F. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424 (2003) 103-107
50. Quong M.W., Harris D.P., Swain S.L., and Murre C. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18 (1999) 6307-6318
51. Rada C., and Milstein C. The intrinsic hypermutability of antibody heavy and light chain genes decays exponentially. EMBO J. 20 (2001) 4570-4576
52. Rada C., Gonzalez-Fernandez A., Jarvis J.M., and Milstein C. The 5′ boundary of somatic hypermutation in a V kappa gene is in the leader intron. Eur. J. Immunol. 24 (1994) 1453-1457
53. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., and Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12 (2002) 1748-1755
54. Rada C., Di Noia J.M., and Neuberger M.S. Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16 (2004) 163-171
55. Ramiro A.R., Stavropoulos P., Jankovic M., and Nussenzweig M.C. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 4 (2003) 452-456
56. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., Eisenreich T.R., Chen J., Dickins R.A., Lowe S.W., Nussenzweig A., and Nussenzweig M.C. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440 (2006) 105-109
57. Raschke E.E., Albert T., and Eick D. Transcriptional regulation of the Ig kappa gene by promoter-proximal pausing of RNA polymerase II. J. Immunol. 163 (1999) 4375-4382
58. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., Tezcan I., Ersoy F., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102 (2000) 565-575
59. Ruckerl F., and Bachl J. Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6. Eur. J. Immunol. 35 (2005) 290-298
60. Ruckerl F., Mailhammer R., and Bachl J. Dual reporter system to dissect cis- and trans-effects influencing the mutation rate in a hypermutating cell line. Mol. Immunol. 41 (2004) 1135-1143
61. Ruckerl F., Busse B., and Bachl J. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines. Mol. Immunol. 43 10 (2006) 1645-1652
62. Sablitzky F., Wildner G., and Rajewsky K. Somatic mutation and clonal expansion of B cells in an antigen-driven immune response. EMBO J. 4 (1985) 345-350
63. Sale J.E., and Neuberger M.S. TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity 9 (1998) 859-869
64. Saribasak H., Saribasak N.N., Ipek F.M., Ellwart J.W., Arakawa H., and Buerstedde J.M. Uracil DNA glycosylase disruption blocks Ig gene conversion and induces transition mutations. J. Immunol. 176 (2006) 365-371
65. Sayegh C.E., Quong M.W., Agata Y., and Murre C. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4 (2003) 586-593
66. Schoetz U., Cervelli M., Wang Y.D., Fiedler P., and Buerstedde J.M. E2A expression stimulates Ig hypermutation. J. Immunol. 177 (2006) 395-400
67. Schreck S., Buettner M., Kremmer E., Bogdan M., Herbst H., and Niedobitek G. Activation-induced cytidine deaminase (AID) is expressed in normal spermatogenesis but only infrequently in testicular germ cell tumours. J. Pathol. 210 1 (2006) 26-31
68. Schroeder S.C., Schwer B., Shuman S., and Bentley D. Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev. 14 (2000) 2435-2440
69. Shen H.M., Peters A., Baron B., Zhu X., and Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280 (1998) 1750-1752
70. Shen H.M., Michael N., Kim N., and Storb U. The TATA binding protein, c-Myc and survivin genes are not somatically hypermutated, while Ig and BCL6 genes are hypermutated in human memory B cells. Int. Immunol. 12 (2000) 1085-1093
71. Shen H.M., Peters A., Kao D., and Storb U. The 3′ Igkappa enhancer contains RNA polymerase II promoters: Implications for endogenous and transgenic kappa gene expression. Int. Immunol. 13 (2001) 665-674
72. Shen H.M., Ratnam S., and Storb U. Targeting of the activation-induced cytosine deaminase is strongly influenced by the sequence and structure of the targeted DNA. Mol. Cell. Biol. 25 (2005) 10815-10821
73. Sohail A., Klapacz J., Samaranayake M., Ullah A., and Bhagwat A.S. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 31 (2003) 2990-2994
74. Spilianakis C.G., Lalioti M.D., Town T., Lee G.R., and Flavell R.A. Interchromosomal associations between alternatively expressed loci. Nature 435 (2005) 637-645
75. Tumas-Brundage K., and Manser T. The transcriptional promoter regulates hypermutation of the antibody heavy chain locus. J. Exp. Med. 185 (1997) 239-250
76. Wang C.L., Harper R.A., and Wabl M. Genome-wide somatic hypermutation. Proc. Natl. Acad. Sci. USA 101 (2004) 7352-7356
77. Wang L., Whang N., Wuerffel R., and Kenter A.L. AID-dependent histone acetylation is detected in immunoglobulin S regions. J. Exp. Med. 203 (2006) 215-226
78. Winter D.B., Sattar N., Mai J.J., and Gearhart P.J. Insertion of 2 kb of bacteriophage DNA between an immunoglobulin promoter and leader exon stops somatic hypermutation in a kappa transgene. Mol. Immunol. 34 (1997) 359-366
79. Woo C.J., Martin A., and Scharff M.D. Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin. Immunity 19 (2003) 479-489
80. Yang S.Y., Fugmann S.D., and Schatz D.G. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences. J. Exp. Med. 203 13 (2006) 2919-2928
81. Yang, S. Y., Fugmann, S. D., Gramlich, H. S., and Schatz, D. G. AID-mediated sequence diversification is transiently targeted to newly integrated DNA substrates. (Submitted for publication.)
82. Yelamos J., Klix N., Goyenechea B., Lozano F., Chui Y.L., Gonzalez Fernandez A., Pannell R., Neuberger M.S., and Milstein C. Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature 376 (1995) 225-229
83. Yoshikawa K., Okazaki I.M., Eto T., Kinoshita K., Muramatsu M., Nagaoka H., and Honjo T. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296 (2002) 2033-2036
84. Zaidi S.K., Young D.W., Choi J.Y., Pratap J., Javed A., Montecino M., Stein J.L., Van Wijnen A.J., Lian J.B., and Stein G.S. The dynamic organization of gene-regulatory machinery in nuclear microenvironments. EMBO Rep. 6 (2005) 128-133